In addition, vimentin is a marker of the epithelial–mesenchymal transition, which is one of several mechanisms that generate myofibroblasts in the kidney and is associated with podocyte dysfunction leading to glomerulosclerosis (LeBleu et al., 2013; Liu, 2010). This evidence concerns the gene VIM and glomerulosclerosis.